Skip to main content

Table 1 Characteristics of the patients with juvenile idiopathic arthritis included in this study

From: Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells

Characteristic

Disease subtype

 

Persistent oligoarticular

(n = 21)

Extended oligoarticular

(n = 16)

Polyarticular

(n = 13)

Female:male

14:7

11:5

8:5

Mean age at sampling in years (± 1 SD)

9.69 (± 4.71)

9.66 (± 3.18)

13.23 (± 5.51)

Mean disease duration in years (± 1 SD)

3.64 (± 4.70)

6.17 (± 3.92)

7.60 (± 5.21)

Number (%) ANA+

17 (80.9%)

11 (68.8%)

3 (23%)

Number (%) RF positive

0 (0%)

0 (0%)

2 (15%)

Number (%) on MTX at time of sampling

3 (14.3%)

8 (50.0%)

8 (61.5%)

Number (%) on Prednisolone at time of sampling

0 (0%)

2 (12.5%)

1 (7.7%)

Number (%) on NSAID at time of sampling

17 (80.9%)

14 (87.5%)

11 (84.6%)

  1. ANA, anti-nuclear antibody; MTX, methotrexate; NSAID, non-steroidal anti-inflammatory; RF, rheumatoid factor antibody; SD, standard deviation.